REJURAN® S 1x1 ml – Targeted Polynucleotide Treatment for Skin Restoration
 
REJURAN® S 1x1 ml is a specialised injectable treatment based on highly purified polynucleotides (PN), developed as part of PharmaResearch's REJURAN® regenerative aesthetics range.
 
REJURAN® S is designed for targeted professional aesthetic treatments where improvement in tissue quality, skin restoration and the appearance of facial wrinkles are primary objectives.
 
Manufactured using PharmaResearch's patented DOT™ (DNA Optimizing Technology), its purified polynucleotide formulation supports the regenerative environment of treated tissue while providing a targeted option within the REJURAN® portfolio.
 
Technology & Composition
REJURAN® S is manufactured using PharmaResearch's patented DOT™ (DNA Optimizing Technology), developed for the purification and optimisation of polynucleotide material.
 
Composition:
Highly purified Polynucleotides (PN)
DNA-derived biomaterial
Manufactured using patented DOT™ Technology
Biocompatible PN injectable gel
Sterile injectable medical device
 
Packaging
Each package contains:
1 pre-filled syringe of 1 ml
 
Indications & Treatment Areas
REJURAN® S is intended for targeted professional aesthetic treatments focused on:
Temporary improvement in the appearance of facial wrinkles
Localised deterioration in skin quality
Areas requiring targeted tissue restoration
Improvement in skin texture
Support for regenerative aesthetic protocols
 
Treatment areas should be selected according to professional clinical assessment and the manufacturer's current Instructions for Use.
 
Clinical Benefits
Targeted PN formulation for localised treatment
Supports tissue restoration
Helps improve the appearance of facial wrinkles
Supports improvement in skin texture
Supports regenerative processes within treated tissue
Provides progressive, natural-looking improvement
Complements the broader REJURAN® regenerative treatment range
Does not primarily act as a conventional volumising dermal filler
 
Treatment Protocol
REJURAN® S is supplied in a ready-to-use 1 ml pre-filled syringe and does not require reconstitution.
Administration technique, treatment depth, quantity and treatment intervals should be determined by an appropriately qualified healthcare professional according to the manufacturer's current Instructions for Use, treatment area and individual patient assessment.
 
REJURAN® S must only be administered by appropriately trained and qualified healthcare professionals.
 
Duration of Results
Improvement develops progressively following treatment.
The duration and degree of improvement vary according to the patient's skin condition, treatment area, clinical indication, injection technique and maintenance protocol.
Repeat or maintenance treatments may be recommended following individual professional assessment.
 
Manufacturer & Regulatory Information
Manufacturer: PharmaResearch
Country of Origin: Republic of Korea
Brand: REJURAN®
Variant: REJURAN® S
Product Type: Injectable Polynucleotide (PN) Medical Device
Technology: DOT™ – DNA Optimizing Technology
Presentation: 1x1 ml
Medical Device Class: Class III
CE Marking: CE 2265
Intended for professional medical use according to the manufacturer's Instructions for Use
 
For Professional Use Only
As a trusted distributor within the medical aesthetics sector, AesthiSave® emphasises that all products supplied are intended exclusively for professional use.
These treatments must only be performed by appropriately qualified healthcare professionals with suitable training and clinical experience, ensuring the highest standards of patient safety and care.